Related Experiment Video
Updated: May 13, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
[Recommendations on use of direct oral anticoagulants in the perioperative period]
Juan V Llau1, Raquel Ferrandis, Jorge Castillo
1Servicio de Anestesiología, Reanimación y Tratamiento del Dolor, Hospital Clínico Universitario de Valencia, Universidad Católica San Vicente Mártir, Valencia, España. juanvllau@gmail.com
Abstract:
Because of the characteristics of direct oral anticoagulants (DOA), the lack of an antidote to completely reverse their anticoagulant effects, the absence of standardization in monitoring of their effects, and limited experience of their use, specific recommendations for their management in the perioperative period or in emergencies are required. In elective surgery, in patients with normal renal function and low hemorrhagic/ thrombotic risk, DOA should be withdrawn 2 days before the intervention; when the hemorrhagic/ thrombotic risk is higher, bridge therapy with a low molecular weight hepatin beginning 5 days before the intervention is proposed as an alternative. In emergency surgery, systematic administration of hemostatic drugs as prophylaxis is not recommended. In DOA-related acute hemorrhage, administration of prothrombin complex concentrate, fresh plasma or factor VIIa should be evaluated, and general measures to control bleeding should be implemented.
Insights
Managing direct oral anticoagulants (DOA) requires specific strategies due to their unique properties. This study outlines recommendations for perioperative and emergency management of these crucial anticoagulant medications.
Area of Science:
- Pharmacology and Therapeutics
- Cardiology
- Anesthesiology
Context:
- Direct oral anticoagulants (DOA) present management challenges due to lack of reversal agents and standardized monitoring.
- Limited clinical experience with DOAs necessitates clear guidelines for perioperative and emergency care.
- Increasing use of DOAs in clinical practice requires evidence-based management protocols.
Purpose:
- To establish specific recommendations for the perioperative and emergency management of patients on direct oral anticoagulants (DOA).
- To provide guidance on drug withdrawal timing and bridging therapy in elective surgery.
- To outline strategies for managing acute hemorrhage related to DOAs.
Summary:
- For elective surgery with normal renal function and low risk, discontinue DOAs 2 days prior. For higher risk, consider bridging with low molecular weight heparin starting 5 days before.
- Prophylactic hemostatic drugs are not recommended in emergency surgery involving DOAs.
- In acute DOA-related hemorrhage, evaluate prothrombin complex concentrate, fresh plasma, or factor VIIa, alongside general hemostatic measures.
Impact:
- Provides clinicians with actionable guidelines for safe and effective management of patients on DOAs during surgical procedures and emergencies.
- Aims to reduce perioperative bleeding complications and optimize thrombotic risk management.
- Facilitates standardized care for patients requiring anticoagulation with DOAs, improving patient outcomes.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease V: Postoperative Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Aneurysm IV: Nursing Management
